Consensus Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Delayed NSE India S.E. Other stock markets 12:59:27 2024-06-05 am EDT			5-day change	1st Jan Change
1,433 ^INR	+1.45%		-1.09%	-2.64%

May. 23	Concord Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
May. 23	Concord Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Concord Biotech Limited

Price target over the last 5 years

History of analyst recommendation changes

d3cde5d13ebd83fef43fce2d44.mfi56Kly-6jS8Y8LCxK4vZlwK7jKJE1Sh1xuCosxYso.8IvT2M8Atcmeq-Y9WEvp7OpHGvWjQgE2wRIqPrpXFoHzzcG8zkO-zqSSwg~71b7d7816d209417eab0b6808ffe1c9b

Analyst Recommendations on Concord Biotech Limited

Jefferies Adjusts Concord Biotech’s Price Target to INR1,410 From INR1,440, Keeps at Hold	Feb. 12	MT
Jefferies Downgrades Concord Biotech to Hold From Buy, Adjusts Price Target to INR1,300 From INR1,260	Nov. 10	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,413 INR

Average target price

1,592 INR

Spread / Average Target

+12.67%

High Price Target

1,716 INR

Spread / Highest target

+21.44%

Low Price Target

1,410 INR

Spread / Lowest Target

-0.21%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Concord Biotech Limited

Jefferies & Co.

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar